Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis-Reference-Cited by-同舟云学术

Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis

Published:2015-10 Issue:10 Volume:122 Page:1976-1986
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Publisher

Elsevier BV

Subject

Ophthalmology

Reference28 articles.

1. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment trial;Kempen;Ophthalmology,2011

2. Periocular corticosteroid injections in uveitis: effects and complications;Sen;Ophthalmology,2014

3. Incidence and risk factors for ocular hypertension in adults with non-infectious uveitis;Daniel;ARVO Meeting Abstracts,2014

4. Risk of elevated intraocular pressure (IOP) in pediatric non-infectious uveitis;Kothari;ARVO Meeting Abstracts,2014

5. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants;Goldstein;Arch Ophthalmol,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Clinical Outcomes of the 0.18 Mg Fluocinolone Acetonide Intravitreal Implant Following Local Corticosteroid Burst in Noninfectious Uveitis;Ocular Immunology and Inflammation;2024-01-09

3. Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes;American Journal of Ophthalmology;2023-10

4. Corticosteroid implants for chronic non-infectious uveitis;Cochrane Database of Systematic Reviews;2023-08-29

5. Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis;Translational Vision Science & Technology;2023-03-28